IL1B and central nervous system cancer: Swaroop et al. observed a significant increase in IL-1β and HSP60 levels in non-infectious brain diseases such as glioma, AD, PD, and stroke, reporting that HSP60 regulates the expression of IL-1β in activated microglial cells [16].